NovaBay Pharma (NBY) Tops Q4 EPS by 2c, Beats on Revenues
Get Alerts NBY Hot Sheet
Price: $0.11 --0%
EPS Growth %: -270.0%
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: -270.0%
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Note: EPS may not be comparable
NovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $6.32 million versus the consensus estimate of $5.97 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- China Automotive Systems (CAAS) Tops Q4 EPS by 24c ; Offers Guidance
- Zura Bio (ZURA) Appoints Robert Lisicki as CEO, Reports FY23 Results
- Walgreens Boots Alliance (WBA) Tops Q2 EPS by 38c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!